Bayer, Novartis clash with UK doctors over use of cheap eye drug

LONDON (Reuters) - Bayer is weighing legal action and Novartis has expressed concern at plans by doctors in the north of England to defy official guidance by using a cancer medicine as a cheap eye drug.